Thyroid Cancer More Common Among Transgender Female Veterans
Transgender female veterans appear to have a high prevalence of thyroid cancer, according to a recent study that might be the first to demonstrate such a disparity in that cohort.
Transgender female veterans appear to have a high prevalence of thyroid cancer, according to a recent study that might be the first to demonstrate such a disparity in that cohort.
Monoclonal gammopathy of undetermined significance (MGUS) is not considered a hematological condition of concern, yet it is associated with lower overall survival. VA researchers led by Lawrence Liu, MD, of the St. Louis VAMC, explored whether the reduced life expectancy arose from an increased risk of cardiovascular events.
Glucagon-like peptide 1 (GLP-1) receptor agonists have gained huge popularity as they have demonstrated the ability to substantially reduce both blood-glucose levels and weight. In addition, recent research suggests cardiovascular and renal benefits to their use in certain populations.
As Vietnam-era veterans move into the age range in which most myeloproliferative neoplasms (MPNs) develop, the VA has a keen interest in fully understanding the full impact of exposure to Agent Orange in veterans with these malignancies.
Women veterans have shown a lack of improvement in cardiac mortality compared to civilian women over nearly two decades, suggesting a need for clinical interventions to improve cardiovascular care, according to a recent study.